News about our portfolio and insights from the vc world
Pioneering Photovoltaic Solutions for Greenhouses
Voltiris, our Serpentine Ventures portfolio company, is advancing greenhouse technology with its innovative photovoltaic modules. Under the leadership of Nicolas Weber, the company is gearing up for an international roadshow. Read more.
Properti Appoints Laurent Spindler as CFO
Properti, our Serpentine Ventures portfolio company, appoints Laurent Spindler as CFO to drive the company's targeted, sustainable growth. Congratulations on this achievement and we are excited to support their continued success.
Introducing the OmniSuit: A Game-Changer in Exoskeleton Tech
Serpentine Ventures portfolio company Auxivo reveals the new Auxivo OmniSuit, the first fully integrated multitask exoskeleton that introduces a new level of versatility. Be the first to see it in action at upcoming fairs.
Biped Gears up for Boston Investor Presentation
Venturelab has interviewed Maël Fabien, founder of our Serpentine Ventures portfolio company Biped. As part of the Swiss National Medtech Team 2023, Biped is set to unveil its revolutionary AI copilot innovation to investors in Boston.
Three Serpentine Ventures Portfolio Companies Featured in TOP 100 Swiss Startups
Our Serpentine Ventures portfolio companies, Properti AG, Isochronic AG and Auxivo AG were recognized as being part of the TOP 100 Swiss Startup Awards 2023. Congratulations and we remain committed to supporting their continued success.
Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites
Piomic, our Swiss Diabetes Venture Fund portfolio company, enrolls first patients in MAVERICKS U.S. study after Medicare Category B designation. FDA-approved IDE study sets groundwork for device authorization and commercialization.